Dexmedetomidine for Continuous Sedation

NCT00226785 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Conscious Sedation

Interventions

DRUG: Dexmedetomidine

Sponsor

Orion Corporation, Orion Pharma